Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 209Thoracic 4Gynecologic 3Sarcoma 2Plasma cell 1CNS 1

Conditions

Ovarian Neoplasms 12Peritoneal Neoplasms 9Stomach Neoplasms 8Neoplasm Metastasis 7Colorectal Neoplasms 7Fallopian Tube Neoplasms 5Endometrial Neoplasms 5Triple Negative Breast Neoplasms 4Colonic Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Non-Small-Cell Lung 4Squamous Cell Carcinoma of Head and Neck 3Rectal Neoplasms 3Neoplasms 3Melanoma 3Esophageal Neoplasms 3Uterine Neoplasms 2Urinary Bladder Neoplasms 2Pseudomyxoma Peritonei 2Pancreatic Neoplasms 2Lung Neoplasms 2Gestational Trophoblastic Disease 2Cholangiocarcinoma 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Appendiceal Neoplasms 2Vipoma 1Uterine Cervical Neoplasms 1Teratoma, Ovarian 1Somatostatinoma 1

Interventions

Early Intervention, Educational 6Oxaliplatin 5Methods 4Cisplatin 4pembrolizumab 3Trastuzumab 3Surveys and Questionnaires 3Specimen Handling 3Leucovorin 3Fluorouracil 3Carboplatin 3X-Rays 2Radiotherapy 2Observation 2Magnetic Resonance Spectroscopy 2Magnetic Resonance Imaging 2Irinotecan 2Interleukin-12 Subunit p35 2Gemcitabine 2Cyclophosphamide 2Counseling 2Cetuximab 2Capecitabine 2Biopsy 2veliparib 1ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1sodium thiosulfate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Rectal Neoplasms × Leucovorin × Gynecologic × Clear all
NCT06607185 2026-05-26

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Eli Lilly and Company

Phase 1 Active not recruiting
750 enrolled
GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT00766142 2025-08-29

COCHISE

Institut Bergonié

Phase 2 Terminated
18 enrolled 9 charts
GastrointestinalGynecologic

Colonic Neoplasms, Peritoneal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00769405 2016-08-30

Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer

UNICANCER

Phase 3 Completed
264 enrolled
GastrointestinalGynecologic

Colonic Neoplasms, Peritoneal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡